Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hartmann

Showing results (41-50 of 198) with videos related to

Pageof 20
Sort By:
BMC Nephrology|June 30, 2012
Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trialInger H Bleskestad, Harald Bergrem, Anders Hartmann, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipientsIngar Holme, Bengt C Fellström, Alan G Jardine, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 23, 2003
[Is current practice concerning living donors in kidney transplantations acceptable?]Lars Westlie, Torbjørn Leivestad, Hallvard Holdaas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2005
Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damageJøran Hjelmesaeth, Fredrik Müller, Trond Jenssen, et al.
Clinical Transplantation|November 20, 2002
The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantationJøran Hjelmesaeth, Monica Hagen, Anders Hartmann, et al.
Clinical Transplantation|February 5, 2015
Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant functionInger H Bleskestad, Harald Bergrem, Torbjørn Leivestad, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 24, 2014
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantationThea Anine Strøm Halden, Anders Åsberg, Karen Vik, et al.
European Journal of Endocrinology|October 10, 2018
Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational studyEspen Nordheim, Kåre I Birkeland, Anders Åsberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2010
Plasma oxalate following kidney transplantation in patients without primary hyperoxaluriaKatja B P Elgstoen, Linda Flaa Johnsen, Berit Woldseth, et al.
Clinical Transplantation|April 12, 2007
Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipientsMonica Hagen Voytovich, Cecilie Haukereid, Jøran Hjelmesaeth, et al.
Pageof 20

Showing results (41-50 of 198) with videos related to

Sort By:
Pageof 20
BMC Nephrology|June 30, 2012
Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trialInger H Bleskestad, Harald Bergrem, Anders Hartmann, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipientsIngar Holme, Bengt C Fellström, Alan G Jardine, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 23, 2003
[Is current practice concerning living donors in kidney transplantations acceptable?]Lars Westlie, Torbjørn Leivestad, Hallvard Holdaas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2005
Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damageJøran Hjelmesaeth, Fredrik Müller, Trond Jenssen, et al.
Clinical Transplantation|November 20, 2002
The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantationJøran Hjelmesaeth, Monica Hagen, Anders Hartmann, et al.
Clinical Transplantation|February 5, 2015
Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant functionInger H Bleskestad, Harald Bergrem, Torbjørn Leivestad, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 24, 2014
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantationThea Anine Strøm Halden, Anders Åsberg, Karen Vik, et al.
European Journal of Endocrinology|October 10, 2018
Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational studyEspen Nordheim, Kåre I Birkeland, Anders Åsberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2010
Plasma oxalate following kidney transplantation in patients without primary hyperoxaluriaKatja B P Elgstoen, Linda Flaa Johnsen, Berit Woldseth, et al.
Clinical Transplantation|April 12, 2007
Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipientsMonica Hagen Voytovich, Cecilie Haukereid, Jøran Hjelmesaeth, et al.
Pageof 20